Pharmaceutical Enterprise LEK-AM Ltd.
PolandAll drugs from this manufacturer
-
The medicinal product is used in the treatment of patients with moderate to severe Alzheimer's disease.
Dosage form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
-
The medicine is intended for the treatment of patients with moderate to severe Alzheimer's disease. It helps to improve nerve impulse transmission and memory.
Dosage form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
-
The medicine is used to prevent the occurrence of asthma symptoms during the day and at night and helps to control this disease. It also helps to prevent exercise-induced bronchoconstriction.
Dosage form: tablets, chewable
Active substance Dosage sodium montelukast 5 mg ATC: R03DC03
-
The medicine is used for the treatment of asthma (to prevent symptoms during the day and at night and to relieve exercise-induced bronchoconstriction) and to relieve the symptoms of seasonal allergies, such as hay fever.
Dosage form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
-
The medicine is used for the treatment of asthma in children (aged 2 to 5 years) to prevent daytime and nighttime symptoms. It also helps to prevent exercise-induced bronchoconstriction in children over 2 years of age.
Dosage form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
-
The medicine is intended for the treatment of, among others, upper respiratory tract infections (sore throat, tonsillitis, sinusitis), acute otitis media, lower respiratory tract infections (bronchitis, pneumonia), skin and soft tissue infections (erysipelas, impetigo, common acne in adults), and certain sexually transmitted diseases.
Dosage form: tablets, film-coated
Active substance Dosage azithromycin 500 mg ATC: J01FA10
-
The medicine is used in adult patients to reduce the risk of death and cardiovascular events. It is intended for individuals with stable left ventricular dysfunction (ejection fraction ≤ 40%) and clinical symptoms of heart failure (edema) following a recent myocardial infarction.
Dosage form: tablets
Active substance Dosage eplerenone 25 mg furosemide 40 mg ATC: C03EB01
-
The medicine is used in adult patients to reduce the risk of death and cardiovascular events. It is intended for individuals with stable left ventricular dysfunction (ejection fraction ≤ 40%) and clinical symptoms of heart failure (edema) following a recent myocardial infarction.
Dosage form: tablets
Active substance Dosage eplerenone 50 mg furosemide 40 mg ATC: C03EB01
-
The medicine is used in adults to treat high blood pressure (hypertension). It works by dilating blood vessels, which helps to lower blood pressure.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
-
The medicine is intended for the treatment of high blood pressure (hypertension) in adults. It helps lower blood pressure by dilating blood vessels.
Dosage form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
-
The medicine is used for the treatment of osteoporosis in postmenopausal women to reduce the risk of vertebral and hip fractures. It also helps to reduce the risk of spinal fractures in men.
Dosage form: tablets, film-coated
Active substance Dosage sodium alendronate trihydrate No input provided ATC: M05BA04
-
The medicine is used to prevent breathing difficulties caused by asthma (including exercise-induced or nocturnal asthma) and chronic obstructive pulmonary disease (COPD). It also helps to relieve an attack of shortness of breath or wheezing in the airways, although it does not act immediately.
Dosage form: powder for inhalation in hard capsules
Active substance Dosage salmeterol 0.05 mg ATC: R03AC12
-
The medicine is used in the treatment of schizophrenia, manic episodes in bipolar affective disorder, and for the short-term treatment of aggression in people with dementia in Alzheimer's disease or in children and adolescents with behavioral disorders.
Dosage form: tablets, film-coated
Active substance Dosage risperidone 4 mg ATC: N05AX08
-
The medicine is used in the treatment of schizophrenia, manic episodes in bipolar affective disorder, and in the short-term treatment of aggression in people with dementia in Alzheimer's disease or in children and adolescents with behavioral disorders.
Dosage form: tablets, film-coated
Active substance Dosage risperidone 1 mg ATC: N05AX08
-
It is used in the treatment of schizophrenia, manic episodes in bipolar disorder, and for the short-term treatment of aggression in people with dementia in Alzheimer's disease or in children and adolescents with behavioral disorders.
Dosage form: tablets, film-coated
Active substance Dosage risperidone 3 mg ATC: N05AX08
-
The medicine is used in the treatment of schizophrenia, manic episodes in bipolar affective disorder, and for the short-term treatment of aggression in people with dementia in Alzheimer's disease or in children and adolescents with behavioral disorders.
Dosage form: tablets, film-coated
Active substance Dosage risperidone 2 mg ATC: N05AX08
-
The medicine is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery and to treat deep vein thrombosis and pulmonary embolism (as well as to prevent their recurrence).
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing over 30 kg), it is used for the treatment and prevention of clots in the veins or lungs following initial injectable treatment.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
In adults, it is used to prevent strokes and other blood clots (in atrial fibrillation) and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (weighing over 30 kg), it is used for the treatment and prevention of blood clots in the veins or lungs following initial treatment with injections.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01
-
The medicine is used for the short-term treatment of primary insomnia in people over 55 years of age. This includes difficulties falling asleep, maintaining sleep continuity, or poor sleep quality, when insomnia has no other medical, psychological, or environmental cause.
Dosage form: tablets, prolonged release
Active substance Dosage melatonin 2 mg ATC: N05CH01
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and neuroendocrine pancreatic tumors that are in a progressive phase and cannot be surgically removed.
Dosage form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and neuroendocrine pancreatic tumors that are in a progressive phase and cannot be surgically removed.
Dosage form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
-
The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and progressive pancreatic neuroendocrine tumors (pNET) that cannot be surgically removed.
Dosage form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
-
The medicine is used in adults to treat angina pectoris (chest pain caused by coronary artery disease).
Dosage form: tablets, modified release
Active substance Dosage trimetazidine dihydrochloride 35 mg ATC: C01EB15